Loading
NT
Neos Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Eisenstadt Richard I, was filed 13 Dec 2018.
Neos Therapeutics, Inc.: what insiders have been doing
Neos Therapeutics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Neos Therapeutics, Inc. in twelve months, the latest record being from 19 March 2021.
The full history, which starts in 2015, counts 13 purchases against 17 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
116
Thresholds
n/a
Buy Volume
€4M
13 ops. · all time
Sell Volume
€2M
17 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Revenue57.6M
Gross profit35.2M61% margin
Net income-15M-26.1% margin
Last declaration on 19 March 2021
Declarations116 total
23,453 sharesCommon StockSEC:0001104659-21-039226:0
23,453 sharesCommon StockSEC:0001104659-21-039225:0
83,015 sharesCommon StockSEC:0001104659-21-039264:0
446,819 sharesCommon StockSEC:0001104659-21-039176:0
23,453 sharesCommon StockSEC:0001104659-21-039223:0
23,453 sharesCommon StockSEC:0001104659-21-039230:0
24,953 sharesCommon StockSEC:0001104659-21-039224:0
270,171 sharesCommon StockSEC:0001104659-21-039228:0
79,130 sharesCommon StockSEC:0001104659-21-039210:0
126,245 sharesCommon StockSEC:0001104659-21-039174:0
1,390 shares@ US$0.8832.3% of flowCommon StockSEC:0001104659-21-036711:0
14,825 shares@ US$0.84424.0% of flowCommon StockSEC:0001104659-21-036711:1
44,329 shares@ US$0.84440.8% of flowCommon StockSEC:0001104659-21-036716:0
16,985 shares@ US$0.844100.0% of flowCommon StockSEC:0001104659-21-036713:0
23,453 shares0Common StockSEC:0001104659-20-072548:0
23,453 shares0Common StockSEC:0001104659-20-072546:0
23,453 shares0Common StockSEC:0001104659-20-072551:0
23,453 shares0Common StockSEC:0001104659-20-072549:0
23,453 shares0Common StockSEC:0001104659-20-072544:0
23,453 shares0Common StockSEC:0001104659-20-072550:0
23,453 shares0Common StockSEC:0001104659-20-072552:0
100,000 shares0Common StockSEC:0001104659-20-029264:0
290,000 shares0Common StockSEC:0001104659-20-029267:0
100,000 shares0Common StockSEC:0001104659-20-029269:0
5,000 shares@ US$2.16100.0% of flowCommon StockSEC:0001104659-18-072812:0
Canonical exit: 12 Mar 2019 (T+90)
25 of 116 declarations
About Neos Therapeutics, Inc.
Neos Therapeutics, Inc. is a company focused on developing pharmaceutical treatments for attention deficit disorders. It is listed on the XNAS market.
